The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH MM 2018 | How should smoldering multiple myeloma be monitored?
Maria Victoria-Mateos
• 5 Oct 2018
Smoldering multiple myeloma (SMM) is the ideal stage to treat the disease and prevent progression to multiple myeloma (MM). Here, Maria-Victoria Mateos, MD, PhD, of the University of Salamanca, Salamanca, Spain, discusses how SMM should be monitored in terms of biology, clinical aspects, imaging and MRD. This video was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
